These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 24170247

  • 1. Five-year potency preservation after iodine-125 prostate brachytherapy.
    Nishimura S, Yorozu A, Ohashi T, Sakayori M, Yagi Y, Nishiyama T, Saito S, Shiraishi Y, Yoshida K, Toya K, Shigematsu N.
    Int J Clin Oncol; 2014 Oct; 19(5):940-5. PubMed ID: 24170247
    [Abstract] [Full Text] [Related]

  • 2. Long-term potency preservation following brachytherapy for prostate cancer.
    Snyder KM, Stock RG, Buckstein M, Stone NN.
    BJU Int; 2012 Jul; 110(2):221-5. PubMed ID: 22734475
    [Abstract] [Full Text] [Related]

  • 3. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 4. Erectile function after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):437-47. PubMed ID: 15890585
    [Abstract] [Full Text] [Related]

  • 5. Sexual potency following interactive ultrasound-guided brachytherapy for prostate cancer.
    Stock RG, Stone NN, Iannuzzi C.
    Int J Radiat Oncol Biol Phys; 1996 May 01; 35(2):267-72. PubMed ID: 8635932
    [Abstract] [Full Text] [Related]

  • 6. Erectile function durability following permanent prostate brachytherapy.
    Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Kurko BS, Anderson R, Lief JH.
    Int J Radiat Oncol Biol Phys; 2009 Nov 01; 75(3):639-48. PubMed ID: 19303721
    [Abstract] [Full Text] [Related]

  • 7. Sexual function and the use of medical devices or drugs to optimize potency after prostate brachytherapy.
    Whaley JT, Levy LB, Swanson DA, Pugh TJ, Kudchadker RJ, Bruno TL, Frank SJ.
    Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):e765-71. PubMed ID: 22300559
    [Abstract] [Full Text] [Related]

  • 8. Long-term erectile function following permanent seed brachytherapy treatment for localized prostate cancer.
    Ong WL, Hindson BR, Beaufort C, Pharoah P, Millar JL.
    Radiother Oncol; 2014 Jul 01; 112(1):72-6. PubMed ID: 25086852
    [Abstract] [Full Text] [Related]

  • 9. There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapy.
    Solan AN, Cesaretti JA, Stone NN, Stock RG.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1468-74. PubMed ID: 18922652
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol; 2013 Mar 01; 189(3):1014-8. PubMed ID: 23017516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years.
    Stone NN, Stock RG.
    Urology; 2007 Feb 01; 69(2):338-42. PubMed ID: 17320674
    [Abstract] [Full Text] [Related]

  • 16. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
    Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J.
    Brachytherapy; 2015 Feb 01; 14(3):334-41. PubMed ID: 25684438
    [Abstract] [Full Text] [Related]

  • 17. Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.
    Peng LC, Mian OY, Lakshminarayanan P, Huang P, Bae HJ, Robertson S, Habtu T, Narang A, Agarwal S, Greco S, Tran P, McNutt T, DeWeese TL, Song DY.
    Urology; 2020 Jan 01; 135():111-116. PubMed ID: 31454660
    [Abstract] [Full Text] [Related]

  • 18. Erectile function after brachytherapy with external beam radiation for prostate cancer.
    Fujioka H, Ishimura T, Sakai Y, Fujii T, Jo Y, Takenaka A, Fujisawa M.
    Arch Androl; 2004 Jan 01; 50(4):295-301. PubMed ID: 15277008
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Erectile function status is highly associated with prostate-specific antigen bounce in localized prostate cancer patients treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Matsumoto K, Kosaka T, Mizuno R, Ohashi T, Mikami S, Miyajima A, Shigematsu N, Oya M.
    Int J Urol; 2016 Mar 01; 23(3):247-52. PubMed ID: 26663514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.